繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Labcorp扩大PathAI合作伙伴关系,在全国部署数字病理平台

2026-02-23 20:27

  • Labcorp (LH) on Monday said it will expand its collaboration with PathAI to deploy the FDA-cleared AISight Dx digital pathology platform across its national network of anatomic pathology labs and hospital collaborations.
  • Labcorp said the cloud-based platform will support fully digital workflows for slide review, case management and collaboration, and integrate AI-powered image analysis to assist in diagnostics.
  • The company said it will also incorporate digital pathology workflows to support its precision medicine products.
  • The expansion builds on Labcorp’s 2019 strategic investment in PathAI and follows ongoing collaboration in AI-driven clinical trial support and validation of AI-pathology solutions.
  • LH +1.59% premarket to $287.17.
  • Source: Press Release

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。